DR. LAN BO CHEN
Dr. Chen is Professor Emeritus of Pathology at Harvard Medical School. He is the author of over 200 academic publications and is the founder of several successful biotechnology companies and ventures, including Fuji ImmunoPharmaceuticals Corp. and Shionogi BioResearch Corp. (both with Nobel laureate Dr. Susumu Tonegawa); Caxton Life Science Partners; Taiwan Global BioFund; TaiMed Biologics; Mevion Medical Systems; Cancer BioScience; Synta Pharmaceuticals (currently Madrigal Pharmaceuticals); Sequential Medicine (currently EuSol Biotech) and Curamir Therapeutics.
Dr. Chen was elected as a member of the Academia Sinica of Taiwan in 1996. He received his B.S. in chemistry from National Taiwan University, Ph.D. in cell biology from the Massachusetts Institute of Technology, and postdoctoral training at the Cold Spring Harbor Laboratories with Dr. James D. Watson.